The above results indicated that the reduction of Treg cells in SLE was involved with the increased NKG2DLs expression induced by IFN-α, so we treated B6.MRL/lpr mice with neutralizing anti-IFNAR mAb or anti-NKG2D mAb. The gene discussed is KLRK1; the disease is systemic lupus erythematosus.